MARKET NEWS AND UPDATES.
Get notified for Latest News and Market Alerts.
Get notified for Latest News and Market Alerts.
×
On 20 May 2022
Zydus Lifesciences Ltd is quoting at Rs 343, up 2.88% on the day as on 12:49 IST on the NSE. The stock is down 44.42% in last one year
Bemdac (Bempedoic acid), a new class of drug that treats uncontrolled LDL-Cholesterol, despite the use of a maximum tolerated dose of s
Used for managing dyslipidemia and cholesterol
Uptravi (Selexipag) Tablets had annual sales of USD 551mn in the United States.
The pharmaceutical company announced that its subsidiary, Zydus Worldwide DMCC secured a tentative approval from the US-based drug regu
Used in treatment of pulmonary arterial hypertension
The drug will be manufactured at Zydus Hospira.
The two dose regimen for ZyCoV-D was tested in 3100 healthy volunteers more than 12 years of age.
Zydus publishes Phase 3 trial results of Desidustat in the American Journal of Nephrology
Per Order for ETF & Mutual Funds Brokerage
Per Order for Delivery, Intraday, F&O, Currency & Commodity
